Factor VIII
Altuviiio Highly Effective Against Bleeding in Children With Severe Hemophilia A
The phase 3 XTEND-Kids study evaluating antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein (Altuviiio, ...
JUNE 26, 2023
FDA Approves First Hemophilia A With Inhibitors Treatment in 20 Years
Genentech's Hemlibra is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes ...
NOVEMBER 17, 2017
Load more